1

Reddy's loses plea in US on ulcer drug

Dr Reddy's Laboratories may have lost a $100 million profit opportunity with the US Court of Appeals for the Federal Circuit on Monday Read »
Created by sudha1234 Created 24 weeks 3 days ago – Made popular 24 weeks 3 days ago
Category: Business
  • Login to post comments
  • 1

Similar stories

Generic Imitrex: Ranbaxy's loss is Dr Reddy's gain Created 6 weeks 4 days ago
Reddy's Perlecan drops one more new drug plan Created 35 weeks 4 days ago
Dr Reddy's net dips 52% in Q2 Created 11 weeks 1 day ago
Dr Reddy's launches Atocor-R in India Created 32 weeks 1 day ago
Dr Reddy's follows Teva on Nexium Created 31 weeks 1 day ago
Pricing, cost may hit Dr Reddy's AOK bid Created 21 weeks 23 hours ago
Reddy's, US firm in marketing deal Created 18 weeks 1 day ago

User login

Syndicate

Syndicate content